Loading...
•
Dec 31, 2022
Bausch + Lomb Q4 2022 Earnings Report
Bausch + Lomb reported mixed results for Q4 2022, with revenues in line with the previous year but a net loss reported. The company highlighted organic revenue growth across all segments and progress in its separation from Bausch Health.
Key Takeaways
Bausch + Lomb's Q4 2022 revenues were $996 million, in line with Q4 2021. The company reported a GAAP net loss of $1 million, and adjusted EBITDA was $181 million. Organic revenue grew by 5%, driven by growth across all segments. The company is undergoing a CEO transition, with Brent Saunders set to take over in March 2023.
Revenues of $996 million were in line with the fourth quarter of 2021.
GAAP net loss attributable to Bausch + Lomb Corporation was $1 million.
Adjusted EBITDA (non-GAAP) was $181 million.
Organic revenues grew 5%, driven by organic growth across all segments.
Revenue by Segment
Forward Guidance
Bausch + Lomb will provide expectations on its first-quarter 2023 outlook during the call today at 8 a.m. ET; however, given the appointment of Mr. Saunders as CEO and chair of the Board, effective March 6, 2023, the Company will provide full guidance for 2023 when it provides first-quarter 2023 results.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...